Ann: Clinical Outcome Demonstrates Material Benefits for Patients, page-5

  1. 2,892 Posts.
    lightbulb Created with Sketch. 466
    Great result

    We have plenty of funding and the CEO is extremely capable and has done this all before

    I have been in RNV well before IPO and sit in top 20 and have not sold 1 share since IPO and won't be selling any

    I have not sold a share - IMHO - and whilst it will take time (not a hyped sexy tech/medical) - they have outstanding product already in market and products in development

    GLTAH

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
10.5¢
Change
0.000(0.00%)
Mkt cap ! $11.57M
Open High Low Value Volume
10.5¢ 10.5¢ 10.5¢ $13.06K 124.4K

Buyers (Bids)

No. Vol. Price($)
1 84421 10.5¢
 

Sellers (Offers)

Price($) Vol. No.
11.0¢ 3000 1
View Market Depth
Last trade - 12.10pm 30/07/2025 (20 minute delay) ?
RNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.